chr1-56929413-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000066.4(C8B):c.1767C>G(p.Asp589Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000825 in 1,612,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.
Frequency
Consequence
NM_000066.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C8B | NM_000066.4 | c.1767C>G | p.Asp589Glu | missense_variant | Exon 12 of 12 | ENST00000371237.9 | NP_000057.3 | |
C8B | NM_001278543.2 | c.1611C>G | p.Asp537Glu | missense_variant | Exon 13 of 13 | NP_001265472.2 | ||
C8B | NM_001278544.2 | c.1581C>G | p.Asp527Glu | missense_variant | Exon 13 of 13 | NP_001265473.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 251112Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135706
GnomAD4 exome AF: 0.0000877 AC: 128AN: 1459848Hom.: 0 Cov.: 33 AF XY: 0.0000881 AC XY: 64AN XY: 726216
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152230Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74366
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.1767C>G (p.D589E) alteration is located in exon 12 (coding exon 12) of the C8B gene. This alteration results from a C to G substitution at nucleotide position 1767, causing the aspartic acid (D) at amino acid position 589 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
This sequence change replaces aspartic acid with glutamic acid at codon 589 of the C8B protein (p.Asp589Glu). The aspartic acid residue is weakly conserved and there is a small physicochemical difference between aspartic acid and glutamic acid. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the ExAC database. This variant has not been reported in the literature in individuals affected with C8B-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at